In Vitro Activity of Meropenem-Vaborbactam against Clinical Isolates of KPC-Positive Enterobacteriaceae

Vaborbactam (formerly RPX7009) is a novel inhibitor of serine β-lactamases, including Ambler class A carbapenemases, such as KPCs. The current study evaluated the in vitro activity of the combination agent meropenem-vaborbactam against a global collection of 991 isolates of KPC-positive Enterobacter...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Hackel, Meredith A., Lomovskaya, Olga, Dudley, Michael N., Karlowsky, James A., Sahm, Daniel F.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2017
Teme:
Susceptibility
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740317/
https://ncbi.nlm.nih.gov/pubmed/29084745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01904-17
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki